Skip to main content
. Author manuscript; available in PMC: 2020 Jan 10.
Published in final edited form as: Oncologist. 2008 Jun;13(6):679–689. doi: 10.1634/theoncologist.2008-0046

Figure 2.

Figure 2.

Overall survival in 262 pediatric subjects with refractory solid tumors who were enrolled in a phase I trial at the National Cancer Institute (NCI). Survival is plotted from the time of enrollment in the first phase I trial at the NCI.